Crossmark

Clinical Update on the Prevention and Management of Postoperative Crohn’s Disease Recurrence

Published Online: 2024-01-16

Published Print: 2024-02

Authors

Bachour, Salam P.

Click, Benjamin H.
License Information

Text and Data Mining valid from 2024-01-16

Version of Record valid from 2024-01-16
More Information

Article History

Accepted: 27 December 2023

First Online: 16 January 2024

Declarations

:

: SB has no disclosures to report. BC reports consulting/advisory boards for AbbVie, Bristol Meyers Squibb, Janssen, Takeda, Pfizer, Prometheus, TARGET-RWE.

Document is current